Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

3,710.00p
   
  • Change Today:
    -40.00p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,225.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,809
  • Market Cap: £193.65m

Dividend Data

  30-Jun-2430-Jun-2330-Jun-2230-Jun-2130-Jun-20
Total Dividend155.00p152.00p126.00p105.00p88.00p
For more dividend details, click here

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 30-Jun-24 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20
Continuing Operations          
Revenue 13.61 12.82 11.72 10.93 10.31
Operating Profit/(Loss) 10.58 10.03 9.27 8.09 8.18
Net Interest 0.20 0.10 0.01 0.03 0.04
Profit Before Tax 10.60 10.13 9.28 8.12 8.23
Profit After Tax 8.10 8.37 7.67 6.73 7.20
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD 8.10 8.37 7.67 6.73 7.20
Attributable to:          
Equity Holders of Parent Company 8.10 8.37 7.67 6.73 7.20
Minority Interests n/a n/a n/a n/a n/a
           
Continuing EPS          
Earnings per Share - Basic 155.12p 160.63p 147.32p 129.22p 139.41p
Earnings per Share - Diluted 152.86p 158.28p 145.90p 127.94p 137.93p
Earnings per Share - Adjusted 155.12p 160.63p 147.32p 129.22p 139.41p
Continuing and Discontinued EPS          
Earnings per Share - Basic 155.12p 160.63p 147.32p 129.22p 139.41p
Earnings per Share - Diluted 152.86p 158.28p 145.90p 127.94p 137.93p
Earnings per Share - Adjusted 155.12p 160.63p 147.32p 129.22p 139.41p
           
Dividend per Share 155.00p 152.00p 126.00p 105.00p 88.00p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 30-Jun-24 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20
Assets          
Non-Current Assets          
Property, Plant & Equipment 0.48 0.58 0.69 0.84 0.72
Intangible Assets n/a n/a n/a n/a n/a
Investment Properties n/a n/a n/a n/a n/a
Investments 0.43 0.61 0.61 0.61 0.61
Other Financial Assets n/a n/a n/a n/a n/a
Other Non-Current Assets n/a n/a n/a n/a n/a
  0.90 1.19 1.30 1.45 1.33
Current Assets          
Inventories 0.62 0.57 0.46 0.33 0.25
Trade & Other Receivables 6.21 5.81 5.22 4.63 3.65
Cash at Bank & in Hand 6.00 5.72 6.13 6.49 8.08
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets n/a n/a n/a n/a n/a
  12.83 12.10 11.81 11.45 11.97
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 13.73 13.28 13.12 12.91 13.30
           
Liabilities          
Current Liabilities          
Borrowings 1.73 1.20 n/a n/a 0.73
Other Current Liabilities n/a n/a 1.25 1.01 n/a
  1.73 1.20 1.25 1.01 0.73
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings n/a n/a n/a n/a n/a
Provisions 0.02 0.02 0.04 0.08 0.05
Other Non-Current Liabilities n/a n/a n/a n/a n/a
  0.02 0.02 0.04 0.08 0.05
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 1.75 1.22 1.30 1.09 0.78
           
Net Assets 12.00 12.06 11.82 11.82 12.52
           
Capital & Reserves          
Share Capital 0.26 0.26 0.26 0.26 0.26
Share Premium Account 1.47 1.47 1.33 1.33 1.31
Other Reserves n/a n/a n/a n/a n/a
Retained Earnings 10.27 10.33 10.23 10.23 10.95
Shareholders Funds 12.00 12.06 11.82 11.82 12.52
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 12.00 12.06 11.82 11.82 12.52
Cash Flow 30-Jun-24 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20
Net Cash Flow From Operating Activities 8.34 7.80 7.56 6.34 7.68
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities 0.19 0.09 (0.01) (0.23) (0.52)
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities (8.25) (8.30) (7.92) (7.69) (5.62)
Net Increase/Decrease In Cash 0.28 (0.41) (0.37) (1.58) 1.54
Ratios - based on IFRS 30-Jun-24 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20
Continuing Operations          
PE Ratio - Adjusted 28.4 24.0 23.4 30.7 29.8
PEG - Adjusted n/a 2.7 1.7 n/a 1.4
Earnings per Share Growth - Adjusted -3% 9% 14% -7% 22%
Dividend Cover 1.00 1.06 1.17 1.23 1.58
Revenue per Share 260.68p 245.54p 224.52p 2.11p 197.59p
Pre-Tax Profit per Share 203.13p 194.16p 177.75p 1.57p 157.58p
Operating Margin 77.79% 78.29% 79.14% 73.99% 79.35%
Return on Capital Employed n/a n/a n/a n/a n/a
Continuing & Discontinued Operations          
PE Ratio - Adjusted 28.4 24.0 23.4 3,043.7 29.8
PEG - Adjusted n/a 2.7 0.0 n/a 1.4
Earnings per Share Growth - Adjusted -3% 9% 11,194% -99% 22%
Dividend Cover 1.00 1.06 1.17 0.01 1.58
           
Dividend Yield 3.5% 3.9% 3.7% 2.6% 2.1%
Dividend per Share Growth 1.97% 20.63% 20.00% 19.32% 20.55%
Operating Cash Flow per Share 159.86p 149.48p 144.78p 121.41p 147.19p
Cash Incr/Decr per Share 5.42p (7.87p) (7.06p) (0.31p) 29.49p
Net Asset Value per Share (exc. Intangibles) 229.95p 231.12p 226.47p 226.46p 239.88p
Net Gearing -35.58% -37.44% n/a n/a -58.68%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.

 

Top of Page